1. Introduction
===============

In the investigation of the bioactive metabolites from soft corals of Taiwanese waters, many bioactive eunicellin-based diterpenoids have been isolated from wild-type octocoral *Pachyclavularia violacea* \[[@B1-marinedrugs-10-01203],[@B2-marinedrugs-10-01203]\], *Cladiella australis* \[[@B3-marinedrugs-10-01203]\], *Vigularia juncea* \[[@B4-marinedrugs-10-01203]\], *Cladiella hirsute* \[[@B5-marinedrugs-10-01203]\], *Cladiella krempfi* \[[@B6-marinedrugs-10-01203]\], *Klyxum molle* \[[@B7-marinedrugs-10-01203]\], and a cultured soft coral *Klyxum simplex* \[[@B8-marinedrugs-10-01203],[@B9-marinedrugs-10-01203],[@B10-marinedrugs-10-01203],[@B11-marinedrugs-10-01203]\]. Our previous study on the secondary metabolites of a Dongsha Atoll soft coral *K. simplex* Thomson & Dean (Alcyonacea, Alcyoniidae) has resulted in the isolation of a series of new eunicellin-based diterpenoids, simplexins A--O \[[@B12-marinedrugs-10-01203],[@B13-marinedrugs-10-01203]\]. In continuation of our search for metabolites from the Dongsha Atoll soft coral *K. simplex*, we have isolated another four new eunicellin-type metabolites, simplexins P--S (**1--4**) ([Chart 1](#marinedrugs-10-01203-f001){ref-type="fig"}) and a known compound simplexin A (**5**). The structures of **1**--**4** were established by extensive spectroscopic analysis, including careful examination of 2D NMR (^1^H--^1^H COSY, HMQC, HMBC and NOESY) correlations. The cytotoxicity of **1--5** against human erythroleukemia (K562), human leukemia (CCRF-CEM), human breast earcinoma (T47D), and human lymphoid T (MOLT 4) cell lines was investigated. The results showed that compound **3**, being the most cytotoxic, is worthy of further biomedical investigation.

![Structures of Metabolites **1--5**.](marinedrugs-10-01203-g001){#marinedrugs-10-01203-f001}

2. Results and Discussion
=========================

Simplexin P (**1**) was obtained as a white powder. Its molecular formula C~26~H~42~O~7~ was determined by the HRESIMS (*m/z* 489.2827 \[M + Na\]^+^) was which deduced six degrees of unsaturation. The IR absorptions bands at ν~max~ 3255 and 1717 cm^--1^ revealed the presence of hydroxy and ester carbonyl functionalities. The ^13^C NMR spectrum measured in CDCl~3~showed signals of 26 carbons ([Table 1](#marinedrugs-10-01203-t001){ref-type="table"}) which were assigned as six methyls, six sp^3^ methylenes, one sp^2^ methylene, eight sp^3^ methines (including four oxymethines), two sp^3^ and three sp^2^ quaternary carbons (including two ester carbonyls) by DEPT. In the ^13^C NMR spectrum of **1**, two carbonyl resonances at δ 172.6 and 170.2 ppm confirmed the presence of two ester groups. In the ^1^H NMR spectrum of **1** ([Table 2](#marinedrugs-10-01203-t002){ref-type="table"}), one acetate methyl (δ 2.12) and one *n-*butyryloxy \[δ 0.92 (3H, t, *J* = 7.5 Hz), 1.60 (2H, m), and 2.13 (2H, m)\] groups were observed. Moreover, two ^1^H NMR singlet signals at δ 5.13 and 5.46 revealed the presence of one olefinic methylene. In addition, the diagnostic signals at δ 4.17 and 3.58 implied the presence of an ether linkage between C-9 and C-2. On the basis of the above results and by the assistance of ^1^H--^1^H COSY and HMBC experiments ([Figure 1](#marinedrugs-10-01203-f002){ref-type="fig"}), the molecular framework of **1** could be established as an eunicellin-type skeleton. Furthermore, the acetoxy group positioned at C-12 was confirmed by HMBC correlations from oxymethine \[δ 4.89 (H-12)\] and acetate methyl (δ 2.12) to the ester carbonyl carbon at δ 170.2 (C). Thus, the remaining one *n*-butyryloxy group was located at C-3, an oxygen-bearing quaternary carbon resonating at δ 84.4 ppm. On the basis of the above analysis, the planar structure of **1** was established unambiguously.
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###### 

^13^C NMR data for compounds **1**--**4***^a^*.

  Position          1                 2              3              4
  ----------------- ----------------- -------------- -------------- ---------------
  1                 41.7 (CH) *^b^*   43.0 (CH)      43.1 (CH)      41.5 (CH)
  2                 89.8 (CH)         91.6 (CH)      91.4 (CH)      91.4 (CH)
  3                 84.4 (C)          84.5 (C)       84.6 (C)       74.1 (C)
  4                 28.7 (CH~2~)      29.4 (CH~2~)   30.0 (CH~2~)   35.2 (CH~2~)
  5                 35.3 (CH~2~)      35.4 (CH~2~)   30.0 (CH~2~)   35.0 (CH~2~)
  6                 73.0 (CH)         73.5 (CH)      87.3 (CH)      74.1 (CH)
  7                 150.3 (C)         150.3 (C)      145.6 (C)      152.0 (C)
  8                 41.0 (CH~2~)      41.2 (CH~2~)   41.9 (CH~2~)   41.5 (CH~2~)
  9                 78.4 (CH)         79.2 (CH)      78.9 (CH)      78.2 (CH)
  10                50.2 (CH)         45.5 (CH)      45.0 (CH)      46.4 (CH)
  11                71.1 (C)          83.5 (C)       83.3 (C)       82.1 (C)
  12                75.5 (CH)         42.2 (CH~2~)   42.7 (CH~2~)   32.4 (CH~2~)
  13                24.2 (CH~2~)      66.8 (CH)      66.8 (CH)      18.1 (CH~2~)
  14                43.4 (CH)         50.3 (CH)      49.8 (CH)      42.7 (CH)
  15                22.2 (CH~3~)      22.7 (CH~3~)   22.9 (CH~3~)   27.6 (CH~3~)
  16                116.9 (CH~2~)     117.0 (CH)     118.2 (CH)     117.2 (CH~2~)
  17                26.2 (CH~3~)      25.2 (CH~3~)   25.3 (CH~3~)   25.4 (CH~3~)
  18                27.4 (CH)         28.4 (CH)      28.5 (CH)      28.0 (CH)
  19                21.7 (CH~3~)      24.8 (CH~3~)   24.8 (CH~3~)   21.8 (CH~3~)
  20                15.5 (CH~3~)      15.8 (CH~3~)   15.7 (CH~3~)   15.0 (CH~3~)
  3-Ac                                               22.3 (CH~3~)   
                                                     169.9 (C)      
  11-Ac                               22.4 (CH~3~)   22.4 (CH~3~)   22.6 (CH~3~)
                                      170.0 (C)      170.0 (C)      170.3 (C)
  12-Ac             21.2 (CH~3~)                                    
                    170.2 (C)                                       
  3- *n*-Butyrate   13.6 (CH~3~)      13.6 (CH~3~)                  
                    18.4 (CH~2~)      18.6 (CH~2~)                  
                    37.3 (CH~2~)      37.4 (CH~2~)                  
                    172.6 (C)         172.6 (C)                     

*^a^* Spectra recorded at 125 MHz in CDCl~3~ at 25 °C; *^b^* Attached protons were determined by DEPT experiments.
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###### 

^1^H NMR Data for compounds **1**--**4***^a^*.

  ----------------------------------------------------------------------------------------------------------------------------
  Position         1                           2                            3                            4
  ---------------- --------------------------- ---------------------------- ---------------------------- ---------------------
  1                2.42 dd (12.0, 7.5) *^b^*   2.24 dd (11.5, 7.0)          2.20 dd (12.5, 7.0)          2.27 dd (11.5, 7.5)

  2                3.58 s                      3.59 s                       3.58 s                       3.56 s

  4                2.20 m\                     2.17 m\                      2.10 m\                      1.73 m
                   1.80 m                      1.84 m                       1.97 m                       

  5                2.12 m\                     2.10 m\                      2.13 m\                      2.06 m\
                   1.71 m                      1.73 m                       1.54 m                       1.95 m

  6                4.33 dd (11.0, 4.0)         4.30 *br* d (10.5)           4.62 dd (10.5, 2.0)          4.32 *br* d (10.5)

  8                2.84 dd (14.0, 4.5)         2.83 dd (14.0, 5.0)          2.83 dd (13.5, 5.0)          2.86 dd (13.5, 5.5)

                   2.47 d (14.0)               2.47 d (14.0)                2.55 d (13.5)                2.51 d (13.5)

  9                4.17 dd (11.0, 4.0)         4.13 dd (10.5, 4.5)          4.11dd (11.0, 5.0)           4.09 dd (10.0, 5.5)

  10               2.66 dd (11.0, 7.5)         3.08 dd (10.5,7.5)           3.17 dd (10.5, 7.0)          2.96 dd (10.0, 7.5)

  12               4.89 dd (11.7, 4.2)         1.52 m                       1.54 m                       1.44 m

                                               2.41 m                       2.34 dd (13.5, 3.5)          2.25 m

  13               1.61 m\                     3.90 ddd (15.0, 13.2, 4.5)   3.90 ddd (16.0, 11.0, 5.0)   1.34 m
                   1.70 m                                                                                

                                                                                                         1.46 m

  14               1.41 m                      1.26 m                       1.26 t (11.0)                1.19 m

  15               1.59 s                      1.56 s                       1.53 s                       1.16 s

  16               5.13 s\                     5.22 s\                      5.35 s\                      5.30 s\
                   5.46 s                      5.47 s                       5.46 s                       5.61 s

  17               1.21 s                      1.57 s                       1.58 s                       1.54 s

  18               1.92 m                      1.92 m                       1.89 m                       1.79 m

  19               0.95 d (7.0)                1.18 d (7.0)                 1.19 d (7.0)                 0.94 d (7.0)

  20               0.83 d (7.0)                0.96 d (7.0)                 0.97 d (7.0)                 0.78 d (7.0)

  3-acetate                                                                 1.95 s                       

  11-acetate                                   2.00 s                       2.01 s                       2.01 s

  12-acetate       2.12 s                                                                                

  3-*n*-butyrate   0.92 t (7.5)                0.94 t (7.5)                                              

                   1.60 m                      1.59 m                                                    

                   2.13 m                      2.15 m                                                    

  6-OOH                                                                     7.78 s                       
  ----------------------------------------------------------------------------------------------------------------------------

*^a^* Spectra recorded at 500 MHz in CDCl~3~ at 25 °C; *^b^* *J* values are (in Hz) in parentheses.

The relative configuration of **1** was determined by analysis of NOE correlations observed in the NOESY spectrum ([Figure 2](#marinedrugs-10-01203-f003){ref-type="fig"}), which showed NOE interactions between H-1 and H-10, revealing they were both β-oriented. Also, correlations between H-2 and both H~3~-15 and H-14; H-14 and both H-9 and H-12; H-9 and both H-12 and H~3~-17; and H~3~-15 and H-6 suggested that of all of H-2, H-6, H-9, H-12, H-14, H~3~-15 and H~3~-17 were all α-oriented. Thus, the NOESY spectrum indicated that **1** was found to possess the (1*R*\*, 2*R*\*, 3*R*\*, 6*S*\*, 9*R*\*, 10*S*\*, 11*S*\*, 12*R*\*, 14*R*\*)-configuration.

![Key ^1^H--^1^H COSY and HMBC correlations of **1** and **2**.](marinedrugs-10-01203-g002){#marinedrugs-10-01203-f002}

![Selective NOESY correlations of **1** and **3**.](marinedrugs-10-01203-g003){#marinedrugs-10-01203-f003}

Compound **2**, simplexin Q, was assigned as the molecular formula C~26~H~42~O~7~ from its HRESIMS data, appropriate for six degrees of unsaturation. ^1^H and ^13^C NMR spectral data of **2** ([Table 1](#marinedrugs-10-01203-t001){ref-type="table"} and [Table 2](#marinedrugs-10-01203-t002){ref-type="table"}) also showed the presence of one acetoxy group (δ~C~ 170.0, C; 22.4, CH~3~; δ~H~ 2.00, 3H, s) and one *n*-butyryloxy group (δ~C~ 172.6, C; 37.4, CH~2~; 18.6, CH~2~; 13.6, CH~3~; δ~H~ 2.15, 2H, m; 1.59, 2H, m; 0.94, 3H, t, *J* = 7.5 Hz). Comparison of the NMR data of **2** with those of the known compound simplexin A (**5**) \[[@B12-marinedrugs-10-01203]\], revealed that the only difference was the presence of an oxymethine (δ~H~ 3.90; δ~C~ 66.8) at C-13 in **2**, instead of the methylene (δ~H~ 2.27 and 1.44; δ~C~ 18.1) in **5** arising from the substitution of a hydroxy moiety at C-13 in **2**, instead of a methylene moiety at the same carbon in **1**. Furthermore, the molecular framework was also established by ^1^H--^1^H COSY and HMBC experiments ([Figure 1](#marinedrugs-10-01203-f002){ref-type="fig"}). The relative configuration of **2,** deduced using a NOESY spectrum, is similar to that of **5**. In addition, H-13 was found to exhibit a NOE correlation with H-1 but not with H-14, revealing the α-orientation of the hydroxyl group at C-13. Therefore, the structure of **2** was found to possess the (1*R*\*, 2*R*\*, 3*R*\*, 6*S*\*, 9*R*\*, 10*S*\*, 11*R*\*, 13*R*\*, 14*R*\*)-configuration.

Simplexin R (**3**), isolated as a white powder, was assigned a molecular formula C~24~H~38~O~8~ from high resolution ESIMS analysis. The presence of the acetate groups was indicated by IR absorption at 1733 cm^--1^, ^1^H NMR signals ([Table 2](#marinedrugs-10-01203-t002){ref-type="table"}) at δ 1.95 (s, 3H) and 2.01 (s, 3H) and ^13^C NMR ([Table 1](#marinedrugs-10-01203-t001){ref-type="table"}) signals at δ 22.3 (CH~3~), 22.4 (CH~3~), 169.9 (C) and 170.0 (C). The NMR spectral data of **3**showed the presence of a 1,1-disubstituted carbon--carbon double bond (δ~C~ 118.2, CH~2~ and 145.6, C; δ~H~ 5.35, s and 5.46, s) and a hydroperoxy proton (δ~H~ 7.78, s). Comparison of the NMR data of **3** with those of **2**revealed the replacement of the *n*-butyryloxy moiety at C-3 and the hydroxy group at C-6 in **2**by the acetoxy and the hydroperoxy groups in **3**, respectively. The relative configuration of **3**was determined mainly by the assistance of the NOESY experiment. The NOE correlations of **3** indicated that **3** possessed the same configurations for each chiral center as those of **2**.

Simplexin S (**4**) showed the pseudomolecular ion peak \[M + Na\]^+^ at*m/z* 403.2463 in the HRESIMS and the molecular formula was determined as C~22~H~36~O~5~. NMR spectroscopic data of **4** ([Table 1](#marinedrugs-10-01203-t001){ref-type="table"} and [Table 2](#marinedrugs-10-01203-t002){ref-type="table"}) showed the presence of one acetoxy group (δ~C~ 170.3, C; 22.6, CH~3~; δ~H~ 2.01, 3H, s). Comparison of the NMR data of **4** with those of **5**revealed that the only difference between both compounds arises from the replacement of the hydroxy group at C-3 in **4**by one *n*-butyryloxy moiety in **5**. The NOESY spectrum indicated that **4** was found to possess the (1*R*\*, 2*R*\*, 3*R*\*, 6*S*\*, 9*R*\*, 10*S*\*, 11*R*\*, 14*R*\*)-configuration.

The cytotoxicity of compounds **1**--**5** against the proliferation of a limited panel of cancer cell lines, including K562, CCRF-CEM, T47D, and MOLT 4 was evaluated by the Alamar Blue assay, using 5-fluorouracil as a positive control. It was found that **3** showed activity against the proliferation of K-562, CCRF-CEM, T47D, and MOLT 4 cancer cells (ED~50~ values of 7.2 ± 2.4, 2.7 ± 0.1, 13.5 ± 2.8, and 3.8 ± 0.5 µg/mL, respectively) ([Table 3](#marinedrugs-10-01203-t003){ref-type="table"}).

marinedrugs-10-01203-t003_Table 3

###### 

Cytotoxicities of Compounds **1**--**5**.

                   Cell Lines ED~50~ (µg/mL)                             
  ---------------- --------------------------- ------------ ------------ ------------
  **1**            \>20                        12.0 ± 1.6   \>20         30.3 ± 3.4
  **2**            \>20                        \>20         \>20         \>20
  **3**            7.2 ± 2.4                   2.7 ± 0.1    13.5 ± 2.8   3.8 ± 0.5
  **4**            \>20                        13.0 ± 0.9   \>20         16.4 ± 3.1
  **5**            \>20                        17.0 ± 2.9   \>20         18.2 ± 2.6
  5-Fluorouracil   2.3 ± 0.2                   1.8 ± 0.3    9.8 ± 1.5    2.3 ± 0.3

3. Experimental Section
=======================

3.1. General Experimental Procedures
------------------------------------

Melting points were determined using a Fisher-Johns melting point apparatus and were uncorrected. Optical rotations were measured on a JASCO DIP-1000 digital polarimeter. IR spectra were recorded on a JASCO FT/IR-4100 infrared spectrophotometer. ESIMS were obtained with a Bruker APEX II mass spectrometer. NMR spectra were recorded on a Varian Unity INOVA 500 FT-NMR at 500 MHz for^1^H and 125 MHz for ^13^C in CDCl~3~. Si gel 60 (Merck, 230--400 mesh) was used for column chromatography. Precoated silica gel plates (Merck, Kieselgel 60 F~254~, 0.2 mm) were used for analytical TLC. High-performance liquid chromatography was performed on a Hitachi L-7100 HPLC apparatus with a Merck Hibar Si-60 column (250 × 21 mm, 7 µm).

3.2. Animal Material
--------------------

*Klyxum simplex* (230 g, wet wt), was collected by hand using scuba off the coast of Dongsha Atoll, in September, 2006, at a depth of 11 m, and stored in a freezer until extraction. A voucher sample (specimen No. 20060901-1) was deposited at the Department of Marine Biotechnology and Resources, National Sun Yat-sen University.

3.3. Extraction and Separation
------------------------------

The frozen bodies of *K. simplex* (230 g, wet wt) were minced and exhaustively extracted with EtOAc (1 L × 4). The organic extract was evaporated under reduced pressure to give a residue (2.5 g) which was subjected to Si gel column chromatography and eluted with EtOAc in *n*-hexane (0--100%, gradient) to yield 22 fractions. Fractions 10--12 (1.05 g) eluted with EtOAc--*n*-hexane (1:3), were further purified over silica gel using EtOAc--*n*-hexane (1:3 to 1:1) to afford 46 subfractions. Subfraction 37 was also purified by normal phase HPLC using acetone--*n*-hexane (1:2) to afford **3**(0.9 mg, 0.036%). Fractions 13--15 (0.47 g), eluted with EtOAc--*n*-hexane (1:1), were further purified over silica gel using EtOAc--*n*-hexane (1:1) to afford 19 subfractions. Subfraction 17 was separated by normal phase HPLC using acetone--*n*-hexane (1:2) to yield **4** (1.6 mg, 0.064%) whilst subfraction 19 was purified by normal phase HPLC using acetone--*n*-hexane (1:2) to afford **2** (1.3 mg, 0.052%). Fractions 16--19 (0.51 g) eluted with EtOAc--*n*-hexane (2:1), were further purified over silica gel using EtOAc--*n*-hexane (2:1) to afford 4 subfractions. Subfraction 4 was separated by normal phase HPLC using MeOH--CH~2~Cl~2~ (1:30) to afford **1** (3.3 mg, 0.132%).

Simplexin P (**1**): white powder (3.3 mg); mp 179.0--180.0 °C; \[*α*\]*^26^~D~* = −27 (*c* 1.2, CHCl~3~); IR (neat) ν~max~ 3255 (broad) and 1717 cm^--1^; ^1^H and ^13^C NMR data, see [Table 1](#marinedrugs-10-01203-t001){ref-type="table"} and [Table 2](#marinedrugs-10-01203-t002){ref-type="table"}; ESIMS *m*/*z* 489 (100, \[M + Na\]^+^); HRESIMS *m*/*z* 489.2827 (calcd for C~26~H~42~O~7~Na, 489.2828).

Simplexin Q (**2**): colorless oil (1.3 mg); \[*α*\]*^26^~D~* = −11 (*c* 0.8, CHCl~3~); IR (neat) ν~max~ 3410 (broad) and 1732 cm^--1^; ^1^H and ^13^C NMR data, see [Table 1](#marinedrugs-10-01203-t001){ref-type="table"} and [Table 2](#marinedrugs-10-01203-t002){ref-type="table"}; ESIMS *m*/*z* 489 (100, \[M + Na\]^+^); HRESIMS *m*/*z* 489.2830 (calcd for C~26~H~42~O~7~Na, 489.2828).

Simplexin R (**3**): white powder (0.9 mg); mp 167--168 °C; \[*α*\]*^26^~D~* = −27 (*c* 0.4, CHCl~3~); IR (neat) ν~max~ 3395 (broad) and 1733 cm^--1^; ^1^H and ^13^C NMR data, see [Table 1](#marinedrugs-10-01203-t001){ref-type="table"} and [Table 2](#marinedrugs-10-01203-t002){ref-type="table"}; ESIMS *m*/*z* 477 (100, \[M + Na\]^+^); HRESIMS *m*/*z* 477.2467 (calcd for C~24~H~38~O~8~Na, 477.2464).

Simplexin S (**4**): colorless oil (1.6 mg); \[*α*\]*^26^~D~* = −41 (*c* 0.6, CHCl~3~); IR (neat, CHCl~3~) ν~max~ 3354 (broad) and 1716 cm^--1^; ^1^H and ^13^C NMR data, see [Table 1](#marinedrugs-10-01203-t001){ref-type="table"} and [Table 2](#marinedrugs-10-01203-t002){ref-type="table"}; ESIMS *m*/*z* 403 (100, \[M + Na\]^+^); HRESIMS *m*/*z* 403.2463 (calcd for C~22~H~36~O~5~Na, 403.2460).

3.4. Cytotoxicity Testing
-------------------------

Cell lines were purchased from the American Type Culture Collection (ATCC). Cytotoxicity assays of compounds **1**--**5** were performed using the Alamar Blue assay \[[@B14-marinedrugs-10-01203],[@B15-marinedrugs-10-01203]\].

In previous studies, a series of new eunicellin-based diterpenoids were isolated from the cultured and wild-type soft corals *Klyxum simplex*. Our continued investigation on the chemical constituents of wild-type soft coral *K. simplex* has again led to the isolation of four new eunicellin-based diterpenoids, simplexins P--S. Simplexin R (3) exhibited significant cytotoxicity against CCRF-CEM and MOLT 4 cells, and moderate to weak cytotoxicity against K-562 and T47D cells. Also, compounds **1**, **4** and **5** exhibited moderate to weak cytotoxicity toward CCRF-CEM and MOLT 4 cell lines. Besides our research, many recent studies have showed the versatile structures and bioactivities of eunicellin-type compounds \[[@B16-marinedrugs-10-01203],[@B17-marinedrugs-10-01203],[@B18-marinedrugs-10-01203],[@B19-marinedrugs-10-01203],[@B20-marinedrugs-10-01203],[@B21-marinedrugs-10-01203]\]. These studies along with the new simplexins described here suggest that eunicellin-type compounds, in particular 3, are worthy of further biomedical investigation.
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